Sign in

CIK 0001088856 · Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770487658
Phone
650.688.8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$41,067,988
in 15 filings, $36.6M under 10b5-1 plans

Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MAHONEY DAVID L −$12.3M Director sold 8% of stake
  2. Maduck Sean −$11.7M See Remarks sold 91% of stake
  3. Vieira Roberto Wandenkolk −$8.1M President, Oncology sold 95% of stake
  4. Park Kimberly −$3.3M Director sold 100% of stake
  5. Lyon Joseph Douglas −$2.3M See Remarks sold 78% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-19 Robb Gary Charles Chief Business Officer Sale −6,127 $19.57 $120K 36,446
2022-05-18 Robb Gary Charles Chief Business Officer Sale −128 $19.55 $3K 42,573
2022-05-17 Robb Gary Charles Chief Business Officer Sale −28,745 $19.55 $562K 42,701
2022-05-02 Maduck Sean See Remarks Grant or award · Stock Option (Right to Buy) +50,000 50,000
2022-03-18 Robb Gary Charles Chief Business Officer Sale −4,988 $24.67 $123K 71,446
2022-03-17 Robb Gary Charles Chief Business Officer Sale −7,512 $24.68 $185K 76,434
2022-02-02 Guyer William Chief Development Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2022-02-02 Robb Gary Charles Chief Business Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2022-02-02 Maduck Sean Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2022-02-02 Lyon Joseph Douglas Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2022-02-02 Mokari Atabak Chief Financial Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2022-02-02 BELANOFF JOSEPH K Chief Executive Officer Grant or award · Stock Option (Right to Buy) +500,000 500,000
2022-02-02 Hunt Hazel Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2022-01-26 Hunt Hazel Chief Scientific Officer Option exercise +40,000 $3.32 $133K 78,493
2022-01-26 Hunt Hazel Chief Scientific Officer Shares withheld for taxes −25,350 $17.16 $435K 53,143
2022-01-26 Hunt Hazel Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −40,000 0
2021-10-05 Maduck Sean Chief Commercial Officer Option exercise +637 $3.29 $2K 40,661
2021-10-05 Maduck Sean Chief Commercial Officer Sale −637 $20.00 $13K 40,024
2021-10-05 Maduck Sean Chief Commercial Officer Option exercise · Stock Option (Right to Buy) −637 122,602
2021-10-01 Maduck Sean Chief Commercial Officer Option exercise +24,363 $3.29 $80K 64,387

Page 57 of 61 · 1,220 trades